1 – 20 of 32
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Hepatic steatosis aggravates atherosclerosis via small extracellular vesicle-mediated inhibition of cellular cholesterol efflux
(
- Contribution to journal › Article
- 2022
-
Mark
Development of a novel MRCP-score for patients with primary sclerosing cholangitis, and assessment of agreement and prognostic value
(
- Contribution to journal › Published meeting abstract
-
Mark
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
(
- Contribution to journal › Article
- 2020
-
Mark
MARC1 variant rs2642438 increases hepatic phosphatidylcholines and decreases severity of non-alcoholic fatty liver disease in humans
(
- Contribution to journal › Letter
- 2019
-
Mark
Association between physical activity and risk of hepatobiliary cancers: A multinational cohort study
(
- Contribution to journal › Article
-
Mark
Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration
(
- Contribution to journal › Article
-
Mark
lLver stiffness measurement: An alternative practical predictor for early kidney dysfunction in patients with non-alcoholic fatty liver disease
(
- Contribution to journal › Published meeting abstract
- 2017
-
Mark
Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD
(
- Contribution to journal › Article
-
Mark
Cartilage oligomeric matrix protein associates with hepatic inflammation and fibrosis in hepatitis C virus infection
(
- Contribution to journal › Debate/Note/Editorial
- 2016
-
Mark
The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans
(
- Contribution to journal › Letter
- 2015
-
Mark
Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2
(
- Contribution to journal › Article
- 2014
-
Mark
A population-based study on the prevalence of NASH using scores validated against liver histology.
(
- Contribution to journal › Article
-
Mark
Fatigue and liver transplantation in patients with primary primary biliary cirrhosis.
(
- Contribution to journal › Letter
- 2012
-
Mark
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro
(
- Contribution to journal › Article
- 2010
-
Mark
Cyld: A Key Regulator Of Hepatocellular Apoptosis, Proliferation And Carcinogenesis
2010) 45th Annual Meeting of the European-Association-for-the-Study-of-Liver- In Journal of Hepatology 52. p.32-33(
- Contribution to journal › Published meeting abstract
-
Mark
Quantitative assessment of the antiviral potencies of 21 shRNA vectors targeting conserved, including structured, hepatitis B virus sites
(
- Contribution to journal › Article
-
Mark
Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis.
(
- Contribution to journal › Article
- 2009
-
Mark
CONTINUED HEAVY TRANSMISSION OF HCV IN A NEEDLE EXCHANGE PROGRAM THAT IS ASSOCIATED WITH MINIMAL TRANMISSION OF HIV. A NINE YEAR LONGITUDINAL COHORT STUDY
2009) 44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver In Journal of Hepatology 50(Suppl 1). p.161-161(
- Contribution to journal › Published meeting abstract
-
Mark
Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients
(
- Contribution to journal › Article
-
Mark
RIBAVIRIN (RBV) DOSAGE AS INDEPENDENT PREDICTOR OF RVR IN HCV GENOTYPE 2 (HCV-2) AND 3 (HCV-3) PATIENTS UNDERGOING COMBINED TREATMENT WITH PEG INTERFERON (PEG-IFN) ALPHA-2B
2009) 44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver In Journal of Hepatology 50(Suppl 1). p.232-232(
- Contribution to journal › Published meeting abstract